“…Studies of obstructive airway disease comprised a significant portion of articles published is 2022. Clinical studies of COPD examined diagnosis [ 2 ], risk factors [ 3 ], predictors of outcomes [ 4 – 9 ], and therapeutic interventions [ 10 , 11 ], whereas preclinical investigations evaluated chronic cigarette smoke-induced inflammation and airway remodeling [ 12 , 13 ]. Contributions in the field of asthma included physiological studies [ 14 – 18 ], effects of therapeutic interventions [ 19 ], social determinants of clinical outcomes [ 20 ], asthma-associated cough [ 21 , 22 ] and preclinical investigations [ 23 ].…”